Logo image
Babesia gibsoni: Detection during experimental infections and after combined atovaquone and azithromycin therapy
Journal article   Peer reviewed

Babesia gibsoni: Detection during experimental infections and after combined atovaquone and azithromycin therapy

R. Jefferies, U.M. Ryan, J. Jardine, I.D. Robertson and P.J. Irwin
Experimental Parasitology, Vol.117(2), pp.115-123
2007
url
Link to Published Version *Subscription may be requiredView

Abstract

Babesia gibsoni is a protozoan parasite of dogs worldwide yet both an effective treatment and a reliable method for detecting subclinical cases of this emerging infection remain elusive. Experimental B. gibsoni infections were established in vivo to investigate the efficacy of combined atovaquone and azithromycin drug therapy and to determine the detection limits of a nested-PCR, IFAT and microscopy during various stages of infection. While atovaquone and azithromycin produced a reduction in parasitaemia, it did not eliminate the parasite and drug resistance appeared to develop in one dog. Polymerase chain reaction was found to be most useful in detecting infection in the pre-acute and acute stages, while IFAT was most reliable during chronic infections. Microscopy is suggested to be only effective for detecting acute stage infections. This study also describes the detection of B. gibsoni in tissue samples during chronic infections for the first time, suggesting possible sequestration of this parasite.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.258 Zoonotic Diseases
1.258.227 Tick-borne Pathogens
Web Of Science research areas
Parasitology
ESI research areas
Microbiology
Logo image